CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer (Q78027476)
Jump to navigation
Jump to search
scientific article published on 01 June 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer |
scientific article published on 01 June 1999 |
Statements
CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer (English)
M G Selzer
B Zhu
N L Block